Combatting antimicrobial resistance; COMBACTE battles antimicrobial resistance by speeding up the development of new antibiotics. There are four main projects, each focused on a specific domain.
COMBACTE-NET is building strong clinical, laboratory and research networks. Enabling more efficient testing of novel antimicrobial drugs. And performing trials.
COMBACTE-MAGNET focuses on critically ill patients in intensive-care units. And on the Gram-negative bacteria that cause most ICU-associated infections.
COMBACTE-CARE is dedicated to meet the challenge of carbapenem-resistant bacteria. Laying the groundwork for tests of new and more effective treatments.
COMBACTE-CDI’s primary goal is to develop a detailed understanding of the epidemiology and clinical impact of Clostridium difficile infection across Europe.
The backbone of all COMBACTE-projects consists of four specialized European networks
CLIN-Net maintains an up-to-date portfolio of clinical trial sites.
LAB-Net maintains an extensive network of microbiology laboratories.
EPI-Net connects and harmonizes various systems of disease surveillance.
In STAT-Net statistical experts join forces to optimize trial design.